Bio-Rad Laboratories, Inc. Class B

$312.16
USD
Last updated on --.
24h volume59.00
24h highest312.17 USD
24h lowest294.55 USD
24h Price movement+16.73%

BIO.B recent prices

24 Hours
+16.73%+$44.73
30 days
-2.22%-$6.650
60 days
----
90 days
+9.18%+$24.68

Key data

Previous close267.43 USD
Market cap7.16B USD
Volume59.00
P/E ratio42.400000
Dividend yield (TTM)0.00%
Dividend amount--
Next ex-dividend date--
Next payment date--
EPS diluted (TTM)6.3100 USD
Net income (FY)168.80M USD
Revenue (FY)2.59B USD
Last report date30 Apr 2026

About Bio-Rad Laboratories, Inc. Class B

LABORATORY ANALYTICAL INSTRUMENTS
HeadquartersHERCULES
Employees (FY)7.45K
Revenue per employee (FY)347.64K USD
Net income per employee (FY)22.66K USD
Listed onNew York Stock Exchange
Official website

BIO.B conversion tables

BIO.BBIO.B
USDUSD
0.5 BIO.B156.08 USD
1 BIO.B312.16 USD
5 BIO.B1,560.84 USD
10 BIO.B3,121.69 USD
USDUSD
BIO.BBIO.B
0.5 USD0.0016017 BIO.B
1 USD0.0032034 BIO.B
5 USD0.016017 BIO.B
10 USD0.032034 BIO.B

FAQ

BIO.B is trading at $312.16, +16.73% over the last 24 hours. Track live moves on the price chart at the top of this page.
The BIO.B stock forecast depends on a mix of factors — broader market conditions, sector trends, and company-specific drivers like earnings, product cycles, and macro signals. BIO.B is currently trading at $312.16, +16.73% over the last 24 hours, which reflects how the market is pricing these factors today. For a longer-term outlook on BIO.B price action, review the 30-day, 60-day, and 90-day performance shown above, monitor momentum across the LABORATORY ANALYTICAL INSTRUMENTS sector, and watch overall market sentiment. Stock forecasts and price predictions are inherently uncertain — always DYOR.
P/E ratio (Price-to-Earnings, trailing twelve months) measures how much investors pay per dollar of earnings over the last 12 months. BIO.B's P/E ratio is currently 42.400000 — calculated by dividing its share price by its trailing 12-month earnings per share (EPS). A higher P/E suggests investors expect stronger future growth from BIO.B; a lower P/E may indicate the stock is undervalued or that the market is pricing in a weaker outlook. P/E ratios are most useful when compared against BIO.B's historical range and other companies in the LABORATORY ANALYTICAL INSTRUMENTS sector.
Bio-Rad Laboratories, Inc. Class B's market cap is currently 7.16B USD. Market cap is calculated as stock price × total shares outstanding.

Disclaimer

The social content on this page ("Content"), including but not limited to tweets and statistics provided by LunarCrush, is sourced from third parties and provided "as is" for informational purposes only. OKX does not guarantee the quality or accuracy of the Content, and the Content does not represent the views of OKX. It is not intended to provide (i) investment advice or recommendation; (ii) an offer or solicitation to buy, sell or hold digital assets; or (iii) financial, accounting, legal or tax advice. Digital assets, including stablecoins and NFTs, involve a high degree of risk and can fluctuate greatly. The price and performance of the digital assets are not guaranteed and may change without notice.

OKX does not provide investment or asset recommendations. You should carefully consider whether trading or holding digital assets is suitable for you in light of your financial condition. Please consult your legal/tax/investment professional for questions about your specific circumstances. For further details, please refer to our Terms of Use and Risk Warning.
24h volume59.00
24h highest312.17 USD
24h lowest294.55 USD
24h Price movement+16.73%
BIO.BBIO.B
USDUSD
Start trade with BIO.B Perpetual